English | Español

Pfizer
Jamie Barrand | Nov 3, 2015

Pfizer slates Xeljanz presentations at American College of Rheumatology/Association of Rheumatology Health Professionals meeting
+ Regulatory
Wendell Hutson | Oct 16, 2015

Pfizer to pay out grants for projects that target breast cancer worldwide

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes